Total Payments
$437,076
2024 Payments
$4,146
Companies
65
Transactions
1,946
Medicare Patients
8,051
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$355,300 (81.3%)
Food & Beverage$52,569 (12.0%)
Travel$15,908 (3.6%)
Consulting$13,081 (3.0%)
Education$218.03 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $355,300 | 208 | 81.3% |
| Food and Beverage | $52,569 | 1,550 | 12.0% |
| Travel and Lodging | $15,908 | 163 | 3.6% |
| Consulting Fee | $13,081 | 6 | 3.0% |
| Education | $218.03 | 19 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $151,187 | 361 | $0 (2024) |
| Amgen Inc. | $71,373 | 276 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $70,597 | 182 | $0 (2024) |
| Lilly USA, LLC | $46,314 | 137 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $46,059 | 189 | $0 (2024) |
| Amarin Pharma Inc. | $18,424 | 113 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $17,107 | 43 | $0 (2024) |
| ABBVIE INC. | $2,450 | 98 | $0 (2024) |
| Novo Nordisk Inc | $1,808 | 70 | $0 (2024) |
| Allergan, Inc. | $1,138 | 22 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,146 | 169 | Corcept Therapeutics ($503.19) |
| 2023 | $6,641 | 177 | Bayer Healthcare Pharmaceuticals Inc. ($2,653) |
| 2022 | $23,154 | 207 | Bayer HealthCare Pharmaceuticals Inc. ($14,060) |
| 2021 | $28,130 | 205 | Amgen Inc. ($11,896) |
| 2020 | $64,651 | 214 | AstraZeneca Pharmaceuticals LP ($25,083) |
| 2019 | $103,790 | 331 | AstraZeneca Pharmaceuticals LP ($40,855) |
| 2018 | $105,764 | 317 | AstraZeneca Pharmaceuticals LP ($46,899) |
| 2017 | $100,799 | 326 | AstraZeneca Pharmaceuticals LP ($28,741) |
All Payment Transactions
1,946 individual payment records from CMS Open Payments — Page 2 of 78
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.44 | General |
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Obesity | ||||||
| 10/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.53 | General |
| Category: GI | ||||||
| 10/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Endocrinology | ||||||
| 10/07/2024 | Corcept Therapeutics | Korlym (Drug) | Education | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 10/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Bone Health | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $110.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 09/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,232 | 3,800 | $607,419 | $316,141 |
| 2022 | 17 | 2,009 | 3,454 | $565,721 | $296,112 |
| 2021 | 16 | 1,789 | 3,254 | $403,439 | $276,023 |
| 2020 | 19 | 2,021 | 3,227 | $339,610 | $256,276 |
Total Patients
8,051
Total Services
13,735
Medicare Billing
$1.1M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 444 | 1,316 | $283,882 | $148,234 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 286 | 533 | $83,240 | $42,229 | 50.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 253 | 259 | $51,801 | $26,276 | 50.7% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 162 | 167 | $34,736 | $18,253 | 52.5% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 113 | 113 | $26,216 | $13,801 | 52.6% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 114 | 114 | $24,738 | $13,258 | 53.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $21,670 | $11,468 | 52.9% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 114 | 114 | $17,442 | $9,327 | 53.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 188 | 507 | $12,720 | $6,485 | 51.0% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 31 | 97 | $10,864 | $5,707 | 52.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 119 | 120 | $8,280 | $5,473 | 66.1% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 116 | 116 | $6,612 | $4,356 | 65.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 20 | 20 | $11,175 | $3,690 | 33.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 29 | $4,422 | $2,320 | 52.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 42 | $3,930 | $2,147 | 54.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,120 | $2,049 | 49.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 157 | $1,571 | $1,066 | 67.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 435 | 1,256 | $269,796 | $148,368 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 298 | 578 | $85,096 | $46,732 | 54.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 280 | 290 | $67,139 | $31,263 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $23,478 | $11,533 | 49.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 94 | 94 | $23,654 | $11,484 | 48.6% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 95 | 95 | $15,641 | $7,933 | 50.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 121 | 123 | $10,396 | $5,618 | 54.0% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2022 | 14 | 88 | $9,164 | $5,251 | 57.3% |
About Dr. Matin Sharafatkhah, M.D
Dr. Matin Sharafatkhah, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013953975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matin Sharafatkhah, M.D has received a total of $437,076 in payments from pharmaceutical and medical device companies, with $4,146 received in 2024. These payments were reported across 1,946 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($355,300).
As a Medicare-enrolled provider, Sharafatkhah has provided services to 8,051 Medicare beneficiaries, totaling 13,735 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Brooklyn, NY
- Active Since 06/21/2006
- Last Updated 10/07/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1013953975
Products in Payments
- FARXIGA (Drug) $140,325
- Repatha (Biological) $68,982
- JARDIANCE (Drug) $58,934
- TRULICITY (Drug) $31,863
- TOUJEO (Drug) $27,287
- SOLIQUA (Drug) $22,882
- Vascepa (Drug) $18,424
- Kerendia (Drug) $17,107
- BYDUREON (Drug) $10,593
- SOLIQUA 100/33 (Drug) $7,360
- SOLIQUA 100/33 (Biological) $6,491
- TOUJEO (Biological) $6,239
- EVENITY (Biological) $1,004
- LINZESS (Drug) $867.32
- Rybelsus (Drug) $755.80
- LEQVIO (Drug) $648.68
- Prolia (Biological) $648.33
- VIBERZI (Drug) $594.02
- XIFAXAN (Drug) $581.20
- Ozempic (Drug) $517.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Brooklyn
Dr. Matvey Brokhin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $373,852
Endocrinology, Diabetes & Metabolism $373,852
Dr. Robert Silver, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $354,536
Endocrinology, Diabetes & Metabolism $354,536
Alexander Perkelvald, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $343,784
Endocrinology, Diabetes & Metabolism $343,784
Dr. Iraklii Buziashvili, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $122,903
Endocrinology, Diabetes & Metabolism $122,903
Dr. Saka Kazeem, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $23,364
Endocrinology, Diabetes & Metabolism $23,364
Dr. Miroslawa Kudej, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,117
Endocrinology, Diabetes & Metabolism $17,117